Clinical trials
Prediction clinical trials
Below are recruiting prediction clinical trials, each written for real people, not researchers. We’re tracking 1,121 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07349277Recruiting
Predicting preeclampsia with blood tests in pregnancy
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
Nasiriyah, Dhi QarAges 18–45 - NCT07349901Recruiting
Predicting hospital readmission after surgery using smart devices
This trial uses a smartwatch and smart ring to collect health data after elective surgery. The goal is to see if these sensors can help predict who might need to return to the hospital, so doctors can provide better follow-up care.
Manaus, AmazonasAges 18 years+ - NCT07350785Recruiting
Predicting outcomes after hip fracture using MDW
This trial checks if a blood test called MDW (monocyte distribution width) can help predict complications and recovery in older adults after a hip fracture.
Kifissia, AtticaAges 65 years+ - NCT07354295Recruiting
Using AI to predict treatment response in esophageal cancer
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
Wuhan, Other (Non U.s.)Ages Any age - NCT07357571Recruiting
Can ultrasound help predict lymph node spread in early thyroid cancer?
This trial uses contrast-enhanced ultrasound before surgery to see if it can predict whether cancer has spread to lymph nodes in patients with early-stage papillary thyroid cancer. The goal is to improve treatment planning without unnecessary surgery.
Guangdong, GuangzhouAges Any age - NCT07367789Recruiting
Predicting recovery after knee replacement using smart insoles
This study uses special insoles to measure how you walk before and after a knee replacement. The goal is to see if these measurements can help predict how well you will recover after surgery.
Yongin-si, Gyeonggi-doAges 19 years+ - NCT07370597Recruiting
Using scans to predict PSMA therapy response in prostate cancer
This study is testing whether a special scan (dosimetry) can help predict how well PSMA radioligand therapy works for men with advanced prostate cancer that has spread. The therapy uses a radioactive drug to target and kill cancer cells that have a protein called PSMA.
BrusselsAges Any age - NCT07378683Recruiting
Predicting infection risk after brain or spinal tumor surgery
This study is building a tool to predict the risk of surgical site infection after brain or spinal tumor surgery. It may help you understand your personal infection risk before your procedure.
Beijing, PUMCAges Any age - NCT07379554Recruiting
Infection Risk Prediction After Transplant
This study is for people who have had a stem cell or solid organ transplant. It aims to predict who might get a serious infection and help doctors manage their care better.
Pavia, LombardyAges Any age - NCT07388108Recruiting
Predicting heart rhythm problems after heart surgery
This trial studies whether measuring how the upper chambers of the heart work together can help predict dangerous heart rhythms after heart surgery. If you are in normal heart rhythm and not having mitral valve surgery, this study may help doctors better prevent complications.
Mendoza, MendozzAges 18–80 - NCT07393048Recruiting
Personalized ctDNA test to predict rectal cancer treatment response
This trial uses a personalized blood test (ctDNA-MRD) to see how well neoadjuvant therapy works for rectal cancer. If you have stage II or III rectal cancer that can be surgically removed, this study might help guide your treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT07393412Recruiting
Heart and vessel disease study for Korean patients at Samsung Medical Center
This study looks at people who have visited Samsung Medical Center for heart or blood vessel problems. It aims to find what factors affect their health over time, which could help doctors predict and prevent future issues.
SeoulAges Any age - NCT07396259Recruiting
PD-L1 test in blood to predict immunotherapy success
This trial is monitoring changes in a cancer protein called PD-L1 in head and neck cancer patients before and during immunotherapy treatment. It aims to better understand how well immunotherapy will work by using regular blood tests.
Taoyuan, CityAges 18 years+ - NCT01985984Recruiting
Predicting outcomes after head and neck radiotherapy
This study looks at how outcomes may be predicted for people with head and neck cancer who receive radiotherapy. It may help doctors better estimate results and tailor follow-up care.
MaastrichtAges 18 years+ - NCT00948116Recruiting
Blood and urine tests to predict kidney injury in diabetes
This study checks whether a set of blood and urine tests can predict “acute kidney injury” (a sudden worsening of kidney function) earlier in people with diabetes who are undergoing a heart procedure. If the tests work, they may help doctors spot kidney trouble sooner and protect your kidneys.
LondonAges 18 years+ - NCT01732523Recruiting
Check if extra blood-vessel growth predicts stroke risk in carotid narrowing
This study looks at an imaging test to see whether signs of new blood-vessel growth in an artery predict future stroke risk in people who have carotid artery narrowing but no symptoms. If it works, it could help doctors identify who may need closer monitoring or preventive treatment.
BaselAges 18 years+ - NCT02434003Recruiting
Test a new way to predict scoliosis curve progression
This study follows adolescents with idiopathic scoliosis to see how well a new predictive model estimates whether the spinal curve will get worse over time. It may help doctors plan monitoring and treatment more accurately for young people with scoliosis.
San Diego, CaliforniaAges 10–15 - NCT02808260Recruiting
Tracking what predicts abnormal heart rhythms after pacemaker
This study looks for patterns that can predict an abnormal heart rhythm called SCAF in people who have a pacemaker or defibrillator. The goal is to help doctors recognize risk earlier and respond sooner if it happens.
Ottawa, OntarioAges 18 years+ - NCT02434445Recruiting
Blood and urine tests to predict kidney failure in cirrhosis
This study checks new blood and urine tests to predict who with advanced liver scarring (cirrhosis) will develop hepatorenal syndrome, a serious kidney problem. The results may help doctors spot risk earlier, especially for people being referred for a liver transplant.
Hong KongAges 18–90 - NCT02302482Recruiting
Tracking memory changes and personal independence over time
This study follows people who are newly evaluated in a memory clinic to better understand what predicts how memory and independence may change. It may help clinicians plan care that supports autonomy as the condition progresses.
Caluire-et-CuireAges 65 years+ - NCT02573636Recruiting
Testing genes in prostate cancer after radiation relapse
This study looks at specific gene changes (TMPRSS2-ERG fusion and PTEN deletion) in people whose prostate cancer returned after radiation. It aims to understand who may have a higher risk of relapse and help predict outcomes after salvage or radical radiation.
Chicoutimi, QuebecAges 18 years+ - NCT02576925Recruiting
Predicting the cause of brief double vision episodes
This trial looks at a way to predict what causes short-lasting double vision. It may help doctors choose the right next steps faster after symptoms stop.
ParisAges 18 years+ - NCT03357926Recruiting
Building predictions for atrial fibrillation in pacemaker patients
This study creates a database to better predict who with a pacemaker or ICD will develop atrial fibrillation (an irregular heart rhythm). It may help your care team spot risk earlier and tailor monitoring sooner.
GrazAges 18 years+ - NCT03321045RecruitingEarly Phase 1
PET scan to predict benefit from HER2-targeted breast cancer therapy
This early-phase study uses a special PET scan with a drug tagged for imaging to predict how well HER2-targeted treatments will work. It may help doctors choose the most effective therapy for HER2-positive breast cancer.
Birmingham, AlabamaAges 18 years+
Hear when a new Prediction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prediction?
- Yes. Clin2 currently lists 1,121 recruiting prediction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prediction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prediction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.